Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: Does cisplatin versus carboplatin make a difference? - Reply

被引：0
|
作者：
D'Addario, G [1 ]
Pintilie, M
Shepherd, FA
机构：
[1] Kantonsspital St Gallen, St Gallen, Switzerland
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 25期
关键词：
D O I：
10.1200/JCO.2005.02.0321
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6277 / 6278
页数：2
相关论文
共 50 条
  • [1] Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: Does cisplatin versus carboplatin make a difference?
    Tiseo, M
    Boni, L
    Ardizzoni, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6276 - 6277
  • [2] Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: A meta-analysis of the published literature
    D'Addario, G
    Pintilie, M
    Leighl, NB
    Feld, R
    Cerny, T
    Shepherd, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2926 - 2936
  • [3] Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
    Georgoulias, V
    Papadakis, E
    Alexopoulos, A
    Tsiafaki, X
    Rapti, A
    Veslemes, M
    Palamidas, P
    Vlachonikolis, I
    LANCET, 2001, 357 (9267): : 1478 - 1484
  • [4] First-Line Chemotherapy Treatment of Advanced Non-Small-Cell Lung Cancer Does Cisplatin versus Carboplatin Make a Difference?
    Tiseo, Marcello
    Ardizzoni, Andrea
    Boni, Luca
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : E82 - E82
  • [5] Non-platinum-based paclitaxel combinations in advanced non-small-cell lung cancer
    Le Chevalier, T
    ONCOLOGY-NEW YORK, 1999, 13 (09): : 48 - 50
  • [6] Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles
    Rossi, Antonio
    Di Maio, Massimo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (06) : 653 - 660
  • [7] PLATINUM-BASED POLYCHEMOTHERAPY VERSUS DIANHYDROGALACTITOL IN ADVANCED NON-SMALL CELL LUNG-CANCER
    EAGAN, RT
    INGLE, JN
    FRYTAK, S
    RUBIN, J
    KVOLS, LK
    CARR, DT
    COLES, DT
    OFALLON, JR
    CANCER TREATMENT REPORTS, 1977, 61 (07): : 1339 - 1345
  • [8] Second-line Paclitaxel/Carboplatin Versus Vinorelbine/Carboplatin in Patients Who Have Advanced Non-Small-Cell Lung Cancer Pretreated With Non-Platinum-Based Chemotherapy: A Multicenter Randomized Phase II Study
    Pallis, Athanasios G.
    Syrigos, Kostas
    Kotsakis, Athanasios
    Karachaliou, Niki
    Polyzos, Aris
    Chandrinos, Vassilis
    Varthalitis, Ioannis
    Christophyllakis, Charalambos
    Ardavanis, Alexandros
    Vamvakas, Lambros
    Vardakis, Nikolaos
    Saridaki, Zacharenia
    Samonis, George
    Giassas, Stylianos
    Georgoulias, Vassilis
    Agelaki, Sophia
    CLINICAL LUNG CANCER, 2011, 12 (02) : 100 - 105
  • [9] Platinum-Based Versus Non-Platinum-Based Chemotherapy as First Line Treatment of Inoperable, Advanced Gastric Adenocarcinoma: A Meta-Analysis
    Chen, Wei-Wei
    Wang, Feng
    Xu, Rui-Hua
    PLOS ONE, 2013, 8 (07):
  • [10] Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
    Lee, Jong Seok
    Lee, Ki Hyeong
    Cho, Eun Kyung
    Kim, Dong-Wan
    Kim, Sang-We
    Kim, Joo-Hang
    Cho, Byoung Chul
    Kang, Jin Hyoung
    Han, Ji-Youn
    Min, Young Joo
    Park, Keunchil
    LUNG CANCER, 2018, 122 : 234 - 242
12345